HOME >> BIOLOGY >> NEWS
Mark Estelle of Indiana University awarded Kumho International Science Prize

Indiana University Professor Mark Estelle has been awarded the 2006 Kumho International Science Prize by the Kumho Cultural Foundation of Seoul, Korea and its chairman, Sam Koo Park. The awards process was administered on behalf of the Kumho Cultural Foundation by the American Society of Plant Biologists.

After considering a number of possible awardees, each responsible for major discoveries in plant science, the selection committee chose Dr. Estelle for elucidating the mechanism of action of auxin, an essential regulator of plant growth and development. These studies recently culminated in the identification of the auxin receptor by Estelle's group and by Ottoline Leyser at the University of York. There had been exhaustive, multi-year searches by laboratories across the globe for this elusive finding.

Upon being notified that Dr. Estelle had won the award, ASPB President Michael Thomashow said "This is wonderful news about Mark. He is a superb scientist who has made seminal contributions to our understanding of hormone signaling. He is highly deserving of the prestigious Kumho International Science Prize."

Dr. Estelle commented, "I am very grateful and honored to be selected to receive the Kumho award. It is a tremendous endorsement of the work we are doing here at Indiana University."

The award ceremony will take place at the Kumho Art Gallery/Kumho Art Hall in Seoul, South Korea June 23, 2006. A $30,000 prize is included with the award, along with Dr. Estelle's round-trip travel to the award ceremony. Dr. Estelle will also speak on his research during the ASPB awards symposium at the Society's annual meeting in Chicago in 2007.

The year 2006 is the first year in which ASPB administered the award selection for the Kumho Cultural Foundation. The selection was previously done by the International Society of Plant Molecular Biologists. Dr. Roger Hangarter, ASPB Immediate Past President, notified Dr. Estelle o
'"/>

Contact: Brian Hyps
bhyps@aspb.org
301-251-0560
American Society of Plant Biologists
24-Jan-2006


Page: 1 2

Related biology news :

1. Agronomy, crop, soils research presented in Indianapolis
2. Rock on! Indiana limestone: NISTs first and latest SRM
3. Indiana University scientists research success puts Indiana in new stem cell business
4. Lilly Endowment gives Indiana University $53 million for life sciences
5. Indiana University one of the nations best places to work, scientists say
6. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
7. A study by the MUHC and McGill University opens a new door to understanding cancer
8. Biologists at Tufts University discover 1 reason why chromosomes break, often leading to cancer
9. $9M grant awarded to University of Cincinnati for bipolar disorder research
10. University of Leeds strengthens China links in membrane and neurobiology
11. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.

Post Your Comments:
(Date:12/17/2014)... Va. , Dec. 15, 2014 ... to make it easier to detect and prevent ... Today the agency started performing an ... capability will validate the authenticity of purchased microcircuits ... The new quality control measures will be conducted ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/17/2014)... AUSTIN, Texas , Dec. 16, 2014  Vermillion, ... company focused on gynecologic disease, today announced the next ... into a premier bio-analytics solutions provider with the naming ... to President and Chief Executive Officer, while current Chairman ... will continue to serve as Chairman. These changes are ...
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/17/2014)... , Dec. 17, 2014   Synageva BioPharma ... company developing therapeutic products for rare disorders, announced today ... being held in San Francisco, CA. ... and Chief Executive Officer, will present on Monday, January ... The presentation will be webcast live and may be ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , Dec. ... BCLI ), a leading developer of adult stem ... subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a grant ... Office of the Chief Scientist (OCS).  This is ... of grant support from the Office of the Chief ...
Breaking Biology Technology:Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
Cached News: